Nadia Mensali

6PUBLICATIONS
23CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Radiation therapyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 08, 2023
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.

Nadia Mensali, Hakan Köksal, Sandy Joaquina

|Oct 29, 2021
Peptide vaccine targeting mutated <i>GNAS</i>: a potential novel treatment for pseudomyxoma peritonei.

Kjersti Flatmark, Annette Torgunrud, Karianne G Fleten

|Nov 29, 2019
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Nadia Mensali, Marit Renée Myhre, Pierre Dillard

|Jun 20, 2019
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Nadia Mensali, Marit Renée Myhre, Pierre Dillard

|Feb 07, 2019
Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity.

Nadia Mensali, Amalie Grenov, Niladri Bhusan Pati

|Dec 18, 2017
Human c-SRC kinase (CSK) overexpression makes T cells dummy.

Else Marit Inderberg, Nadia Mensali, Morten P Oksvold

Pageof 1

Frequent Collaborators

5 joint publications

Else Marit Inderberg

5 joint publications

Sébastien Wälchli

3 joint publications

Pierre Dillard

3 joint publications

Gustav Gaudernack